| Title | Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients. |
| Publication Type | Journal Article |
| Year of Publication | 2011 |
| Authors | Vergara-Rodriguez, Pamela, Mary Jo Tozzi, Michael Botsko, Vijay Nandi, Frederick Altice, James E. Egan, Patrick G. O'Connor, Lynn E. Sullivan, and David A. Fiellin |
| Corporate Authors | BHIVES Collaborative |
| Journal | Journal of acquired immune deficiency syndromes (1999) |
| Volume | 56 Suppl 1 |
| Pagination | S62-7 |
| Date Published | 2011 Mar 1 |
| ISSN | 1944-7884 |
| Keywords | Anti-HIV Agents, Buprenorphine, Cohort Studies, Dose-Response Relationship, Drug, Drug Interactions, Drug-Induced Liver Injury, HIV Infections, Humans, Naloxone, Oligopeptides, Opioid-Related Disorders, Pyridines |
| Abstract | The safety of buprenorphine/naloxone (bup/nx) in HIV-infected patients has not been established. Prior reports raise concern about hepatotoxicity and interactions with atazanavir. |
| DOI | 10.1182/blood-2011-06-362194 |
| Alternate Journal | J. Acquir. Immune Defic. Syndr. |
